top of page

Rivermount Management LLC

Rivermount VC Fund

VC Fund, Investment Management and consulting

About

Rivermount VC Fund is a small VC fund based in the San Francisco Bay Area – Silicon Valley, with registration in Delaware, USA.

Our goal is to seek high-quality investment opportunities in high tech and healthcare industries for high-net-worth families and achieve asset appreciation brought by leading technological innovations, simultaneously making a modest contribution to global innovation with funding.

Philosophy

The right people

The right technology

The right time

The right market

Portfolio

PORTFOLIO OF THE FUND

Combinati

Screenshot 2024-01-07 at 8.28.54 PM.png

DTx Pharma

Screenshot 2024-01-07 at 8.28.57 PM.png

BryoLogyx

Screenshot 2024-01-07 at 8.29.01 PM.png

BioTrace Medical

Screenshot 2024-01-07 at 8.29.04 PM.png

EuMentis Therapeutics

Screenshot 2024-01-07 at 8.29.08 PM.png

PetDx

Screenshot 2024-01-07 at 8.29.12 PM.png

Rigimmune

Screenshot 2024-01-07 at 8.29.15 PM.png

InnoSign

Screenshot 2024-01-07 at 8.29.19 PM.png

Trio Pharmaceuticals

Screenshot 2024-01-07 at 8.29.23 PM.png

Solenic Medical

Screenshot 2024-01-07 at 8.29.26 PM.png

Larkspur Bioscience

Screenshot 2024-01-07 at 8.29.28 PM.png

Saccharo

Screenshot 2024-01-07 at 8.29.31 PM.png

Neurava

Screenshot 2024-01-07 at 8.29.34 PM.png

inhalon biopharma

Screenshot 2024-01-07 at 8.29.36 PM.png

Noctrix Health

PORTFOLIO OF THE TEAM BEFORE FOUNDING THE FUND

Screenshot 2024-01-07 at 9.06.57 PM.png

Flexus Biosciences

Screenshot 2024-01-07 at 9.06.53 PM.png

Arcus Biosciences

Screenshot 2024-01-07 at 9.07.04 PM.png

Redlen Technologies

Screenshot 2024-01-07 at 9.07.00 PM.png

Synthomics

Team

The core GP (General Partner) members include successful investment experts with 30 years of investment experience, possessing a deep understanding of macro environments, industry development, and the effective logic and criteria for different investment project evaluation; and a biotech veteran with 30 years of experience with successful track record in drug discovery, development and FDA approval.

 

Advisors include Stanford professors and industry experts with deep insight in the healthcare and tech industries.

bottom of page